On Jul 14, 2021, PathoGene raised $500,000 in a Seed Round from startup founder Joseph Mickel.

About the company: PathoGene is located in California, United States. “PathoGene, Inc. is a private, seed-stage precision MedTech startup headquartered in Los Angeles, with R&D operations located in Monrovia, California. We are developing a sample-to-answer automated in vitro diagnostic medical device that detects and identifies all known microscopic human pathogens along with antimicrobial resistance profiles. Additionally, we leverage cloud-based information systems to automate reporting of notifiable diseases in real-time to disease surveillance systems.”  PathoGene’s technology is licensed from Northern Arizona University and the Translational Genomics Research Institute.

Company website: pathogene.com

Leave a Reply

Your email address will not be published. Required fields are marked *